Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Cash & Equivalents: 2009-2025

Historic Cash & Equivalents for Prestige Consumer Healthcare (PBH) over the last 17 years, with Mar 2025 value amounting to $97.9 million.

  • Prestige Consumer Healthcare's Cash & Equivalents rose 131.09% to $119.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $119.1 million, marking a year-over-year increase of 131.09%. This contributed to the annual value of $97.9 million for FY2025, which is 110.64% up from last year.
  • According to the latest figures from FY2025, Prestige Consumer Healthcare's Cash & Equivalents is $97.9 million, which was up 110.64% from $46.5 million recorded in FY2024.
  • In the past 5 years, Prestige Consumer Healthcare's Cash & Equivalents ranged from a high of $97.9 million in FY2025 and a low of $27.2 million during FY2022.
  • Moreover, its 3-year median value for Cash & Equivalents was $58.5 million (2023), whereas its average is $67.6 million.
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Cash & Equivalents tumbled by 65.91% in 2021, and later surged by 115.15% in 2023.
  • MRY analysis of 5 years shows Prestige Consumer Healthcare's Cash & Equivalents stood at $32.3 million in 2021, then decreased by 15.84% to $27.2 million in 2022, then surged by 115.15% to $58.5 million in 2023, then dropped by 20.55% to $46.5 million in 2024, then surged by 110.64% to $97.9 million in 2025.
  • Its Cash & Equivalents was $97.9 million in FY2025, compared to $46.5 million in FY2024 and $58.5 million in FY2023.